Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ZNF433 contributors: mct - updated : 13-10-2021
HGNC name zinc finger protein 433
HGNC id 20811
DNA
TYPE functioning gene
STRUCTURE 20.96 kb     4 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
4 - 2292 77.11 673 - 2021 34439859
4 - 2283 - 670 - 2021 34439859
5 - 2342 - 638 - 2021 34439859
5 - 2351 - 672 - 2021 34439859
5 - 2330 - 638 - 2021 34439859
6 - 2389 - 638 - 2021 34439859
EXPRESSION
Type
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Reproductivefemale systemuterus   
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • 19 C2H2-type zinc fingers
  • one KRAB domain
  • HOMOLOGY
    Homologene
    FAMILY
  • Krüppel C2H2-type zinc finger protein family
  • CATEGORY tumor suppressor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • may be involved in transcriptional regulation
  • binding partner of CTNNB1 and activated beta-catenin/TCF signaling in prostate cancer
  • possible tumor-suppressor gene in clear-cell renal cell carcinoma
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA binding
    RNA
    small molecule metal binding,
    ion Zn2+
    protein
  • ZNF433 enhanced the binding between CTNNB1 and TCF4
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • prognostic marker in clear-cell renal cell carcinoma
  • Therapy target
    SystemTypeDisorderPubmed
    cancerreproductiveprostate
    ZNF433 was a potential target for the treatment of prostate cancer
    ANIMAL & CELL MODELS